MASI.NASDAQMasimo CORP

Form 4: Masimo Executive Reports Equity Conversion Post-Merger

Sentiment:

Statement of Changes in Beneficial Ownership


Chief Marketing Officer Tim Benner reports the cancellation and conversion of equity holdings following Masimo Corporation's acquisition by Danaher Corporation.

Summary

  • Tim Benner, Chief Marketing Officer of Masimo Corporation, filed a Form 4 detailing the disposition of equity holdings.
  • The transactions occurred on June 10, 2026, in connection with the merger of Masimo Corporation into a subsidiary of Danaher Corporation.
  • Restricted Stock Units (RSUs) were converted into Danaher Corporation RSUs based on a $180.00 per share merger consideration.
  • Stock options and Performance-Based Restricted Stock Units (PSUs) were canceled and converted into the right to receive cash payments based on the $180.00 per share merger price.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing documenting the completion of a previously announced merger.

Positives

  • Equity awards were successfully converted or cashed out at the $180.00 per share merger price, ensuring value realization for the executive.

Negatives

  • The executive no longer holds direct equity in Masimo Corporation as it has become a wholly owned subsidiary of Danaher Corporation.

Risks

  • Integration risks associated with the merger into Danaher Corporation.
  • Potential tax withholding implications on the cash-out of stock options and PSUs.

Future Outlook

Masimo Corporation is now a wholly owned subsidiary of Danaher Corporation; future operations will be integrated into the parent company's structure.

Industry Context

StockSavvy.ai notes that this filing confirms the finalization of the Masimo-Danaher merger, a significant consolidation in the medical technology sector, aligning with broader trends of large-cap life sciences companies acquiring specialized monitoring technology firms.

Comparison to Industry Standards

  • The $180.00 per share acquisition price represents a standard premium-based exit for shareholders in the medical device sector.
  • The conversion of unvested equity into parent company equity is a standard practice in large-scale corporate acquisitions to ensure management retention.

Legal Proceedings

  • The merger was executed pursuant to the Agreement and Plan of Merger dated February 16, 2026.

Stakeholder Impact

  • Shareholders receive $180.00 per share in cash.
  • Employees and executives see equity awards converted or cashed out per merger terms.

Next Steps

  • Final integration of Masimo operations into Danaher Corporation.

Key Dates

DateDescription
06/09/2025Original grant date for certain RSUs and PSUs.
02/16/2026Date of the Agreement and Plan of Merger.
03/06/2026Original grant date for certain RSUs.
06/10/2026Effective time of the merger and transaction date for equity conversions.
06/12/2026Date of filing.

Keywords

Masimo, Danaher, Merger, Form 4, Equity Conversion, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.